ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
Baseline characteristics of eligible patients with HER2+ metastatic breast cancer
| Variables | Eligible patients (n=2,212) |
|---|---|
| Age group, N (%) | |
| 20-29 | 97 (4.4) |
| 30-39 | 422 (19.1) |
| 40-49 | 836 (37.8) |
| 50-59 | 623 (28.2) |
| 60-64 | 115 (5.2) |
| 65+ | 119 (5.4) |
| Sex, N (%) | |
| Male | 7 (0.3) |
| Female | 2,205 (99.7) |
| Type of Insurance, N (%) | |
| Health insurance | 2,127 (96.2) |
| Medical aid | 85 (3.8) |
| Charlson Comorbidity Index |
6.8 (2.9) |
| Charlson Comorbidity Index |
8 (4-8) |
Abbreviations: HER2+, human epidermal growth factor receptor-2 positive; SD, standardized difference; IQR, interquartile range
*calculated during the 1-year period prior to the first prescription of trastuzumab-emtansine.